Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Amyloid-related Imaging Abnormalities (Microbleeds) in Atypical AD

NCT01723553 is registered in ClinicalTrials.gov with Mayo Clinic as lead sponsor.

NCT NCT01723553
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01723553 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Amyloid-related Imaging Abnormalities (Microbleeds) in Atypical AD
Lead sponsor
Mayo Clinic
Phase
Phase 1
Overall status
Completed
Start date
November 30, 2012
Completion date
March 31, 2015
Enrollment
27 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

atypical alzheimers disease, logopenic variant of primary progressive aphasia (lpa), posterior cortical atrophy (pca)